Related references
Note: Only part of the references are listed.Fumarates Promote Cytoprotection of Central Nervous System Cells against Oxidative Stress via the Nuclear Factor (Erythroid-Derived 2)-Like 2 Pathway
Robert H. Scannevin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Treatment of Recurrent Aphthous Stomatitis With Fumaric Acid Esters
Emmanuella Guenova et al.
ARCHIVES OF DERMATOLOGY (2011)
Long-Term Treatment with Fumaric Acid Esters in an 11-Year-Old Male Child with Psoriasis
S. Gerdes et al.
DERMATOLOGY (2011)
Downregulation of endothelial adhesion molecules by dimethylfumarate, but not monomethylfumarate, and impairment of dynamic lymphocyte-endothelial cell interactions
Katrin Wallbrecht et al.
EXPERIMENTAL DERMATOLOGY (2011)
Treatment of granulomatous cheilitis with fumaric acid esters in a young woman
R. Kleine et al.
HAUTARZT (2011)
Dimethylfumarate inhibits MIF-induced proliferation of keratinocytes by inhibiting MSK1 and RSK1 activation and by inducing nuclear p-c-Jun (S63) and p-p53 (S15) expression
B. Gesser et al.
INFLAMMATION RESEARCH (2011)
Malignant melanoma during treatment with fumaric acid esters - coincidence or treatment-related?
Dietrich Barth et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2011)
Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells
Kamran Ghoreschi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Dimethyl Fumarate, an Immune Modulator and Inducer of the Antioxidant Response, Suppresses HIV Replication and Macrophage-Mediated Neurotoxicity: A Novel Candidate for HIV Neuroprotection
Stephanie A. Cross et al.
JOURNAL OF IMMUNOLOGY (2011)
Suppression of VEGFR2 Expression in Human Endothelial Cells by Dimethylfumarate Treatment: Evidence for Anti-Angiogenic Action
Markus Meissner et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis
D. G. MacManus et al.
JOURNAL OF NEUROLOGY (2011)
TRIAL WATCH Phase III success for Biogen's oral multiple sclerosis therapy
[Anonymous]
NATURE REVIEWS DRUG DISCOVERY (2011)
Transient Alteration of Cellular Redox Buffering before Irradiation Triggers Apoptosis in Head and Neck Carcinoma Stem and Non-Stem Cells
Anthony Boivin et al.
PLOS ONE (2011)
Efficacy of Fumaric Acid Esters in the R6/2 and YAC128 Models of Huntington's Disease
Gisa Ellrichmann et al.
PLOS ONE (2011)
Fumaric Acid Esters in Severe Ulcerative Necrobiosis Lipoidica: A Case Report and Evaluation of Current Therapies
Franziska C. Eberle et al.
ACTA DERMATO-VENEREOLOGICA (2010)
Targeting glutathione by dimethylfumarate protects against experimental malaria by enhancing erythrocyte cell membrane scrambling
Mehrdad Ghashghaeinia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Pharmacokinetics of anti-psoriatic fumaric acid esters in psoriasis patients
Martin Rostami-Yazdi et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2010)
Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study
E. M. Wain et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Multiple sclerosis: a practical overview for clinicians
Konrad Rejdak et al.
BRITISH MEDICAL BULLETIN (2010)
Combination of Dacarbazine and Dimethylfumarate Efficiently Reduces Melanoma Lymph Node Metastasis
Teresa Valero et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Cutaneous sarcoidosis: updates in the pathogenesis
M. M. Ali et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2010)
DMF inhibits PDGF-BB induced airway smooth muscle cell proliferation through induction of heme-oxygenase-1
Petra Seidel et al.
RESPIRATORY RESEARCH (2010)
Treatment of Disseminated Granuloma Annulare with Low-dose Fumaric Acid
H. Oliver Weber et al.
ACTA DERMATO-VENEREOLOGICA (2009)
Dimethylfumarate inhibits NF-κB function at multiple levels to limit airway smooth muscle cell cytokine secretion
P. Seidel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)
Dimethylfumarate inhibits tumor cell invasion and metastasis by suppressing the expression and activities of matrix metalloproteinases in melanoma cells
Yuzuru Yamazoe et al.
CELL BIOLOGY INTERNATIONAL (2009)
Wirksamkeit und Sicherheit von Fumarsäureestern in der Langzeittherapie der Psoriasis â Eine retrospektive Studie (FUTURE)
Kristian Reich et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2009)
Detection of Metabolites of Fumaric Acid Esters in Human Urine: Implications for Their Mode of Action
Martin Rostami-Yazdi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Squamous cell carcinoma as a complication of fumaric acid ester immunosuppression
L. Jennings et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Dimethyl fumarate, a small molecule drug for psoriasis, inhibits Nuclear Factor-κB and reduces myocardial infarct size in rats
Silvia Meili-Butz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
Ludwig Kappos et al.
LANCET (2008)
Dimethylfumarate specifically inhibits the mitogen and stress-activated kinases 1 and 2 (MSK1/2): Possible role for its anti-psoriatic effect
Borbala Gesser et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Dimethylfumarate inhibits nuclear binding of nuclear factor κB but not of nuclear factor of activated T cells and CCAAT/enhancer binding protein β in activated human T cells
S. Gerdes et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Dimethylfumarate impairs melanoma growth and metastasis
Robert Loewe et al.
CANCER RESEARCH (2006)
Oral fumaric acid esters for the treatment of active multiple sclerosis:: an open-label, baseline-controlled pilot study
S. Schimrigk et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Glutathione regulates susceptibility to oxidant-induced mitochondrial DNA damage in human lymphocytes
DL Hollins et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Fumaric acid esters in necrobiosis lipoidica:: results of a prospective noncontrolled study
A Kreuter et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Detoxication enzyme inducers modify cytokine production in rat mixed glial cells
A Wierinckx et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Therapy of noninfectious granulomatous skin diseases with fumaric acid esters
K Breuer et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Enhanced cytotoxicity of bioreductive antitumor agents with dimethyl fumarate in human glioblastoma cells
B Gu et al.
ANTI-CANCER DRUGS (2005)
Disseminated granuloma annulare - Treatment with fumaric acid esters
B Eberlein- Konig et al.
DERMATOLOGY (2005)
Successful treatment of sarcoidosis with cutaneous and pulmonary involvement with fumaric acid ester
R Gutzmer et al.
HAUTARZT (2004)
Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: An eotaxin and STAT6-dependent process
J Mattes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Dimethylfumarate is a potent inducer of apoptosis in human T cells
F Treumer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Clearance of necrobiosis lipoidica with fumaric acid esters
T Gambichler et al.
DERMATOLOGY (2003)
Disseminated granuloma annulare - successful therapy with fumaric acid esters
A Schulze-Dirks et al.
HAUTARZT (2001)
Inhibition of dendritic cell differentiation by fumaric acid esters
KJ Zhu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
The antipsoriatic drug dimethylfumarate strongly suppresses chemokine production in human keratinocytes and peripheral blood mononuclear cells
TJ Stoof et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
Expression of IFNγ, coexpression of TNFα and matrix metalloproteinases and apoptosis of T lymphocytes and macrophages in granuloma annulare
A Fayyazi et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2000)
Share Paper
